Singapore markets close in 2 hours 57 minutes

Omicron’s rapid spread shreds budding recovery in air travel

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
62.70-3.51 (-5.30%)
At close: 04:00PM EST
62.70 0.00 (0.00%)
After hours: 04:01PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 3.26B
Enterprise value 2.83B
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)91.07
Price/book (mrq)6.99
Enterprise value/revenue 80.99
Enterprise value/EBITDA -26.74

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-5.82%
S&P500 52-week change 322.59%
52-week high 396.48
52-week low 351.72
50-day moving average 365.60
200-day moving average 373.89

Share statistics

Avg vol (3-month) 3325.87k
Avg vol (10-day) 3326.84k
Shares outstanding 549.25M
Implied shares outstanding 6N/A
Float 826.84M
% held by insiders 112.80%
% held by institutions 194.60%
Shares short (14 Nov 2021) 43.4M
Short ratio (14 Nov 2021) 410.95
Short % of float (14 Nov 2021) 414.73%
Short % of shares outstanding (14 Nov 2021) 46.91%
Shares short (prior month 14 Oct 2021) 43.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 0.00%
Operating margin (ttm)-304.15%

Management effectiveness

Return on assets (ttm)-17.03%
Return on equity (ttm)-28.82%

Income statement

Revenue (ttm)35M
Revenue per share (ttm)0.73
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)35M
Net income avi to common (ttm)-106.57M
Diluted EPS (ttm)-2.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)427.91M
Total cash per share (mrq)8.78
Total debt (mrq)1.62M
Total debt/equity (mrq)0.35
Current ratio (mrq)15.41
Book value per share (mrq)9.59

Cash flow statement

Operating cash flow (ttm)-66.5M
Levered free cash flow (ttm)-25.97M